GE HealthCare Technologies Inc. (GEHC) recently announced the launch of CleaRecon DL, an innovative AI-based deep learning technology designed to enhance 3D cone-beam computed tomography (CBCT) imaging in the interventional suite. This cutting-edge solution aims to significantly reduce streak artifacts caused by pulsatile blood flow and contrast distribution, resulting in clearer, more accurate images for improved patient diagnosis and treatment outcomes. CleaRecon DL recently received FDA 510(k) clearance ...